Vanguard Group Portfolio holdings
Vanguard Group is an investment manager owned by the funds it manages, and so by its own customers. John Bogle founded it in 1975 and is credited with creating the first index fund available to individual investors. After Wellington Management fired Bogle in 1974, he started a new fund division there and named it Vanguard after HMS Vanguard, Horatio Nelson's flagship. Bogle set up its first index fund in 1976, the fund that became the Vanguard 500 Index Fund, and the firm added a bond index fund in 1986. It began offering ETFs in 2001 as exchange-traded shares of its index funds, and it also serves employers' retirement plans and independent financial advisers. Salim Ramji, who came from BlackRock, was named chief executive in 2024 as the first outsider to lead the firm.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$8.03B |
| 2 |
Microsoft
MSFT
|
+$8B |
| 3 |
Apple
AAPL
|
+$7.21B |
| 4 |
TotalEnergies
TTE
|
+$5.18B |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.85B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kellanova
K
|
+$2.74B |
| 2 |
DuPont de Nemours
DD
|
+$2.65B |
| 3 |
Mr. Cooper
COOP
|
+$1.41B |
| 4 |
Interpublic Group of Companies
IPG
|
+$1.24B |
| 5 |
Amazon
AMZN
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32% |
| 2 | Financials | 13.5% |
| 3 | Consumer Discretionary | 9.9% |
| 4 | Healthcare | 9.82% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2726
iShares Russell 1000 Growth ETF
IWF
$118B
| $16M | ﹤0.01% |
135,356
+2,196
| +2% | +$260K |
2023 Q2
10 quarters
|
|
2727
Aura Biosciences
AURA
$740M
| $16M | ﹤0.01% |
2,936,538
+46,035
| +2% | +$273K |
2021 Q4
16 quarters
|
|
2728
Kodiak AI
KDK
$227M
| $15.9M | ﹤0.01% |
+1,455,300
| New | +$11.7M |
2025 Q4
0 quarters
|
|
2729
DELISTED
Olaplex Holdings
OLPX
| $15.9M | ﹤0.01% |
11,853,545
+288,553
| +2% | +$343K |
2021 Q3
17 quarters
|
|
2730
DELISTED
Forte Biosciences
FBRX
| $15.9M | ﹤0.01% |
582,263
+15,522
| +3% | +$272K |
2017 Q2
34 quarters
|
|
2731
eGain
EGAN
$157M
| $15.9M | ﹤0.01% |
1,542,979
-206,647
| -12% | -$2.47M |
2013 Q2
50 quarters
|
|
2732
Benitec Biopharma
BNTC
$315M
| $15.8M | ﹤0.01% |
1,174,758
+182,644
| +18% | +$2.53M |
2023 Q4
8 quarters
|
|
2733
Onity Group
ONIT
$234M
| $15.8M | ﹤0.01% |
345,301
+5,681
| +2% | +$233K |
2013 Q2
50 quarters
|
|
2734
Immersion
IMMR
$230M
| $15.8M | ﹤0.01% |
2,322,319
+745,381
| +47% | +$5.06M |
2013 Q2
50 quarters
|
|
2735
DELISTED
ON24
ONTF
| $15.7M | ﹤0.01% |
1,978,132
-785,137
| -28% | -$4.45M |
2021 Q1
19 quarters
|
|
2736
Vanguard Morningstar Mid-Cap ETF
VO
$108B
| $15.7M | ﹤0.01% |
216,864
+2,196
| +1% | +$160K |
2023 Q1
11 quarters
|
|
2737
Target Hospitality
TH
$1.14B
| $15.7M | ﹤0.01% |
1,955,135
-39,506
| -2% | -$300K |
2019 Q2
26 quarters
|
|
2738
NRC Health Common Stock
NRC
$564M
| $15.6M | ﹤0.01% |
831,379
-90,025
| -10% | -$1.36M |
2013 Q2
50 quarters
|
|
2739
Telos
TLS
$540M
| $15.6M | ﹤0.01% |
3,049,813
+134,922
| +5% | +$842K |
2020 Q4
20 quarters
|
|
2740
Sight Sciences
SGHT
$602M
| $15.5M | ﹤0.01% |
1,948,647
+41,951
| +2% | +$268K |
2021 Q3
17 quarters
|
|
2741
DELISTED
Cross Country Healthcare
CCRN
| $15.4M | ﹤0.01% |
1,904,150
+81,416
| +4% | +$890K |
2013 Q2
50 quarters
|
|
2742
GrafTech
EAF
$261M
| $15.4M | ﹤0.01% |
990,456
-12,468
| -1% | -$190K |
2018 Q2
30 quarters
|
|
2743
Pulse Biosciences
PLSE
$3.71B
| $15.4M | ﹤0.01% |
1,118,743
+5,052
| +0.5% | +$78.7K |
2016 Q4
36 quarters
|
|
2744
LexinFintech Holdings
LX
$103M
| $15.4M | ﹤0.01% |
4,694,443
+51,870
| +1% | +$213K |
2025 Q1
3 quarters
|
|
2745
ZIM Integrated Shipping Services
ZIM
$3.54B
| $15.3M | ﹤0.01% |
722,955
+26,670
| +4% | +$447K |
2021 Q4
16 quarters
|
|
2746
Marex Group Limited Ordinary Shares
MRX
$5.12B
| $15.3M | ﹤0.01% |
399,956
-68,505
| -15% | -$2.33M |
2025 Q2
2 quarters
|
|
2747
Isabella Bank
ISBA
$341M
| $15.3M | ﹤0.01% |
306,685
+60,749
| +25% | +$2.57M |
2025 Q2
2 quarters
|
|
2748
CS Disco
LAW
$432M
| $15.3M | ﹤0.01% |
1,973,365
+14,278
| +0.7% | +$101K |
2021 Q3
17 quarters
|
|
2749
Design Therapeutics
DSGN
$670M
| $15.3M | ﹤0.01% |
1,630,910
+187,209
| +13% | +$1.47M |
2021 Q1
19 quarters
|
|
2750
MapLight Therapeutics
MPLT
$403M
| $15.3M | ﹤0.01% |
+869,668
| New | +$14.6M |
2025 Q4
0 quarters
|
|
Similar funds
Vanguard Group's Q4 2025 Portfolio in Review
As of Q4 2025, Vanguard Group held 4,426 positions worth $6.9T, up 3.3% from $6.68T the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 4.1%. Vanguard Group opened 82 new positions and exited 98, leaving the 4,426-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q4 2025 buy was TotalEnergies: 81,863,403 shares worth $5.34B.
- Vanguard Group added most to NVIDIA in Q4 2025, an estimated $8.03B increase.
- Vanguard Group's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $2.65B.
- Vanguard Group fully exited Kellanova in Q4 2025, selling an estimated $2.74B.
- Vanguard Group's ten largest holdings make up 31% of its $6.9T portfolio in Q4 2025.
- Vanguard Group opened 82 new positions and closed 98 in Q4 2025.
- Vanguard Group's portfolio value rose 3.3% quarter-over-quarter to $6.9T.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.